Mioflazine is primarily used in the field of cardiovascular research due to its properties as a calcium channel blocker. It has been studied for its potential to protect heart tissue during ischemic events, such as heart attacks, by reducing calcium overload in cardiac cells. This mechanism helps in minimizing cell damage and improving recovery post-ischemia. Additionally, Mioflazine has been explored for its anti-arrhythmic effects, which could be beneficial in managing irregular heartbeats. Its application extends to experimental models where it aids in understanding the role of calcium channels in heart function and disease. Overall, Mioflazine serves as a valuable tool in advancing knowledge and developing therapeutic strategies for cardiovascular conditions.